Sickly Healthcare Stocks Are Perking Up. For Contrarian Investors, Buying Now Could Be Just the Remedy to Protect Your Portfolio.
When macro volatility ticks up and tech momentum begins to feel fragile, the Health Care Select Sector SPDR Fund (XLV) is routinely prescribed as the ultimate defensive remedy. This time around, XLV seems like an especially effective treatment for portfolio maladies. This daily chart is encouraging to me. That’s a very promising percentage price oscillator…
